Back to Schonfeld Strategic Advisors LLC Schonfeld Strategic Advisors LLC

PMCBPMCB
Showing 8 of 20 quarters

Position history for Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC's holdings in PHARMACYTE BIOTECH INC

Schonfeld Strategic Advisors LLC holds 26,926 shares of PMCB (PHARMACYTE BIOTECH INC), worth $20,733 as of 2026-Q2. The position was decreased (-0.3% shares). PMCB represents 0.0% of Schonfeld Strategic Advisors LLC's portfolio.

Current Value

$20,733

Current Shares

26,926

Total Value Change

-$28,736

Total Shares Change

+1,026

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
26,926
-0.3%
$20,7330.0%$0.77
0
2026-Q1
Increased
27,009
+3.2%
$17,9710.0%$0.71
19
2025-Q4
Decreased
26,178
-0.1%
$18,9520.0%$0.72
0
2025-Q3
Unchanged
26,200
0.0%
$25,4030.0%$0.98
0
2025-Q2
Increased
26,200
+2.8%
$28,5580.0%$1.03
20
2025-Q1
Decreased
25,500
-0.8%
$31,8750.0%$1.32
0
2024-Q4
Decreased
25,700
-0.8%
$40,3490.0%$1.55
0
2024-Q3
Increased
25,900
+9.3%
$49,4690.0%$1.84
22

Other major holders of PMCB: GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used